Biological: adalimumab|Biological: placebo. Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12|Percentage of Participants With Baseline...
Archive for category: Clinical Trials
An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa., Clinical Trials, Research, Dermatology, Treatment, 0
Drug: 10% Benzoyl Peroxide Topical Body Wash|Drug: Provodine Topical Cream. Hidradenitis Suppurativa European Research Group (HISERG) scale|Skin Irritation Index|Patient...
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa, Clinical Trials, Research, Dermatology, Treatment, 0
Biological: MEDI8968|Biological: Saline. 1) Proportion of subjects achieving a clinically relevant response in Physician Global Assessment (PGA), with score...
To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa, Clinical Trials, Research, Dermatology, Treatment, 0
Drug: adalimumab. To assess the efficacy and safety of adalimumab in subjects with moderate to severe hidradenitis suppurativa. Efficacy...
, Clinical Trials, Research, 0
. Quality of Life (WHOQOL-BREF)|Quality of Life (DLQI)|Quality of Life (FLQA-d)|Quality of Life (Skindex)|Sexual Function|Demographic Parameters|Smoking|Weight and height|Wound assessment
, Clinical Trials, Research, Treatment, 0
Biological: CJM112. Clinical responder rate|Safety and tolerability as measured by frequency of adverse events|Pharmacokinetic profile|Immunogenicity|Safety and tolerability as measured...
HS Patient Stories
HS BOOK SERIES: “I WILL NOT HIDE” Hidradenitis suppurativa (HS)
Our series of book releases for #HSAWARENESS tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by the patients themselves.
“The European Dermatology Forum (EDF) guideline recommends the management of chronic pain in patients with HS according to the World Health Organization (WHO) pain ladder.”
— Ring HC, Theut Riis P, Miller IM, Saunte DM, Jemec GB